Anti- and pro-oxidant effects of urate in copper-induced low-density lipoprotein oxidation.
We reported earlier that urate may behave as a pro-oxidant in Cu2+-induced oxidation of diluted plasma. Thus, its effect on Cu2+-induced oxidation of isolated low-density lipoprotein (LDL) was investigated by monitoring the formation of malondialdehyde and conjugated dienes and the consumption of urate and carotenoids. We show that urate is antioxidant at high concentration but pro-oxidant at low concentration. Depending on Cu2+ concentration, the switch between the pro- and antioxidant behavior of urate occurs at different urate concentrations. At high Cu2+ concentration, in the presence of urate, superoxide dismutase and ferricytochrome c protect LDL from oxidation but no protection is observed at low Cu2+ concentration. The use of Cu2+ or Cu+ chelators demonstrates that both copper redox states are required. We suggest that two mechanisms occur depending on the Cu2+ concentration. Urate may reduce Cu2+ to Cu+, which in turn contributes to formation. The Cu2+ reduction is likely to produce the urate radical (UH.-). It is proposed that at high Cu2+ concentration, the reaction of UH.- radical with generates products or intermediates, which trigger LDL oxidation. At low Cu2+ concentration, we suggest that the Cu+ ions formed reduce lipid hydroperoxides to alkoxyl radicals, thereby facilitating the peroxidizing chain reaction. It is anticipated that these two mechanisms are the consequence of complex LDL-urate-Cu2+ interactions. It is also shown that urate is pro-oxidant towards slightly preoxidized LDL, whatever its concentration. We reiterate the conclusion that the use of antioxidants may be a two-edged sword.
Filipe
Paulo
P
Centro de Metabolismo e Endocrinologia, Faculdade de Medicina de Lisboa, Portugal.
Haigle
Josiane
J
Freitas
João
J
Fernandes
Afonso
A
Mazière
Jean-Claude
JC
Mazière
Cécile
C
Santus
René
R
Morlière
Patrice
P
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D002338:Carotenoids / Q000378:metabolism; D002417:Cattle; D003300:Copper / Q000494:pharmacology*; D004492:Edetic Acid / Q000494:pharmacology; D007668:Kidney / Q000201:enzymology; D007700:Kinetics; D015227:Lipid Peroxidation; D008077:Lipoproteins, LDL / Q000378:metabolism*; D008099:Liver / Q000201:enzymology; D008315:Malondialdehyde / Q000378:metabolism; D008956:Models, Chemical; D016877:Oxidants / Q000494:pharmacology*; D010100:Oxygen / Q000378:metabolism*; D010618:Phenanthrolines / Q000494:pharmacology; D013482:Superoxide Dismutase / Q000378:metabolism; D013997:Time Factors
D000975:Antioxidants; D008077:Lipoproteins, LDL; D016877:Oxidants; D010618:Phenanthrolines; D002338:Carotenoids; D008315:Malondialdehyde; D003300:Copper; C002701:neocuproine; D004492:Edetic Acid; D013482:Superoxide Dismutase; D010100:Oxygen